QOP
MRNA icon

Quinn Opportunity Partners’s Moderna MRNA Stock Holding History

Quinn Opportunity Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-28,000
Closed -$794K – 398
2025
Q1 		$794K Buy
28,000
+11,500
+70% +$408K 0.05% 231
2024
Q4 		$686K Buy
+16,500
New +$789K 0.05% 235

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Quinn Opportunity Partners's MRNA Position: Q2 2025 in Review

Quinn Opportunity Partners sold out of Moderna (MRNA) in Q2 2025, closing a stake of 28,000 shares — an estimated $794K sold.

Quinn Opportunity Partners first reported a position in MRNA in Q4 2024 and held it in 2 quarters. The position peaked at $794K in Q1 2025. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • Quinn Opportunity Partners reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • Quinn Opportunity Partners sold 28,000 Moderna shares in Q2 2025, an estimated $794K.
  • Quinn Opportunity Partners first reported a position in Moderna in Q4 2024 and held it in 2 quarters.
  • Quinn Opportunity Partners's Moderna position peaked at $794K in Q1 2025.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Quinn Opportunity Partners's 13F filing for Q2 2025, filed 8 Aug 2025.